Literature DB >> 16598303

Essential thrombocythemias without V617F JAK2 mutation are clonal hematopoietic stem cell disorders.

J-J Kiladjian, N Elkassar, B Cassinat, G Hetet, S Giraudier, N Balitrand, C Conejero, J Briere, P Fenaux, C Chomienne, B Grandchamp.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16598303     DOI: 10.1038/sj.leu.2404214

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  7 in total

Review 1.  X-linked clonality testing: interpretation and limitations.

Authors:  George L Chen; Josef T Prchal
Journal:  Blood       Date:  2007-04-13       Impact factor: 22.113

2.  Sex differences in the JAK2 V617F allele burden in chronic myeloproliferative disorders.

Authors:  Brady L Stein; Donna M Williams; Nae-Yuh Wang; Ophelia Rogers; Mary Ann Isaacs; Naveen Pemmaraju; Jerry L Spivak; Alison R Moliterno
Journal:  Haematologica       Date:  2010-02-04       Impact factor: 9.941

Review 3.  Potential of human induced pluripotent stem cells derived from blood and other postnatal cell types.

Authors:  Zhaohui Ye; Linzhao Cheng
Journal:  Regen Med       Date:  2010-07       Impact factor: 3.806

4.  Phenotypic variability within the JAK2 V617F-positive MPD: roles of progenitor cell and neutrophil allele burdens.

Authors:  Alison R Moliterno; Donna M Williams; Ophelia Rogers; Mary Ann Isaacs; Jerry L Spivak
Journal:  Exp Hematol       Date:  2008-08-23       Impact factor: 3.084

Review 5.  Essential thrombocythemia.

Authors:  Jean B Brière
Journal:  Orphanet J Rare Dis       Date:  2007-01-08       Impact factor: 4.123

6.  Recent advances in the bcr-abl negative chronic myeloproliferative diseases.

Authors:  Michael Bennett; David F Stroncek
Journal:  J Transl Med       Date:  2006-10-11       Impact factor: 5.531

Review 7.  Is there a gender effect in polycythemia vera?

Authors:  Francesca Palandri; Barbara Mora; Naseema Gangat; Lucia Catani
Journal:  Ann Hematol       Date:  2020-10-02       Impact factor: 3.673

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.